| Entry |
|
|---|
| Name |
Pimasertib (USAN/INN) |
|---|
| Formula |
C15H15FIN3O3
|
|---|
| Exact mass |
431.0142
|
|---|
| Mol weight |
431.20
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Antineoplastic
DG03137 MEK inhibitor
|
|---|
| Remark |
|
|---|
| Efficacy |
Antineoplastic, Mitogen-activated extracellular signal-regulated kinase (MEK) inhibitor |
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Brite |
Drug groups [BR:br08330]
Antineoplastic
DG03137 MEK inhibitor
DG01410 Pimasertib
D10426 Pimasertib
Target-based classification of drugs [BR:br08310]
Protein kinases
Serine/threonine kinases
STE group
MAP2K (MEK)
D10426 Pimasertib (USAN/INN)
Drug groups [BR:br08330]
Antineoplastic
DG03137 MEK inhibitor
DG01410 Pimasertib
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 23
1 C8x C 16.2704 -13.3901
2 C8x C 16.2704 -14.7939
3 C8y C 17.4861 -15.4957
4 C8y C 18.7018 -14.7939
5 C8x C 18.7018 -13.3901
6 C8y C 17.4861 -12.6882
7 X I 17.4861 -11.2847
8 N1b N 17.4861 -16.8993
9 C8y C 16.2536 -17.6111
10 C8x C 15.0463 -16.9141
11 N5x N 13.8307 -17.6160
12 C8x C 13.8308 -19.0198
13 C8x C 15.0379 -19.7167
14 C8y C 16.2536 -19.0148
15 C5a C 17.4776 -19.7215
16 N1b N 18.6890 -19.0222
17 C1b C 19.8732 -19.7059
18 C1c C 21.0709 -19.0142
19 C1b C 22.2619 -19.7019
20 O1a O 23.4562 -19.0121
21 O5a O 17.4774 -21.1107
22 X F 19.9362 -15.5068
23 O1a O 21.0710 -17.6017
BOND 24
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 6 7 1
8 3 8 1
9 8 9 1
10 9 10 2
11 10 11 1
12 11 12 2
13 12 13 1
14 13 14 2
15 9 14 1
16 14 15 1
17 15 16 1
18 16 17 1
19 17 18 1
20 18 19 1
21 19 20 1
22 15 21 2
23 4 22 1
24 18 23 1 #Down
|
|---|
